Private company

SYBLEU Inc

SYBLEU Inc is an American pharmaceutical preparations company, incorporated in Wyoming.¹ It is headquartered in Bronx, New York.¹

Last updated Oct 21, 2026.

Overview

$11.7KRevenue, fiscal 2023²

-$180.3KNet income, fiscal 2023²

From the company’s reports to the SEC. Every number links to the filing it came from.

-1275.5%Operating margin²

-1541.6%Net margin²

-0.0%Revenue growth, 2023²

Research and development

Out of $11.7K in revenue.² The company lost money this year.

Revenue⁴²$11.7K in 2023+189% since 2021

Operating income⁴²-$149.2K in 2023+69% since 2021

Net income⁴²-$180.3K in 2023+77% since 2021

Fiscal year	2021	2022	2023
Revenue	$4.1K⁴	$11.7K²	$11.7K²
Research and development	$29.4K⁴	$5.1K²	$85.5K²
Operating expenses		$68.1K²	$160.9K²
Operating income	-$88.3K⁴	-$56.4K²	-$149.2K²
Income before tax		-$245.3K²	-$180.3K²
Income tax	$21.4K⁴	$0⁴
Net income	-$101.8K⁴	-$245.3K²	-$180.3K²

Total assets⁸⁴²$330.5K in 2023+3765% since 2020

Total liabilities⁸⁴²$681.4K in 2023+5915% since 2020

Shareholders’ equity⁴²-$350.9K in 2023

Cash⁸²$3.8K in 2023−25% since 2020

Fiscal year	2020	2021	2022	2023
Cash	$5.0K⁸	$14.3K⁸	$66.8K²	$3.8K²
Current assets	$8.6K⁸	$14.3K⁴	$66.8K²	$19.4K²
Total assets	$8.6K⁸	$199.5K⁴	$76.4K²	$330.5K²
Short-term debt			$170.4K²
Current liabilities	$11.3K⁸	$30.8K⁴	$164.6K²	$231.4K²
Total liabilities	$11.3K⁸	$204.2K⁴	$326.3K²	$681.4K²
Retained earnings			-$351.1K²	-$531.4K²
Shareholders’ equity	$40.9K⁴	-$198.7K²	-$266.1K²	-$350.9K²
Shares outstanding	9.4M shares⁸	10.4M shares⁸	10.4M shares⁴	10.6M shares²

Cash from operations⁴²-$100.6K in 2023+14% since 2021

Fiscal year	2020	2021	2022	2023
Cash from operations		-$88.3K⁴	-$78.5K²	-$100.6K²
Cash from financing			$131.1K²	$37.5K²

May 23, 20248-K Change of auditor⁹
May 8, 20248-K Change of auditor¹⁰
Apr 18, 20248-K Entered a material agreement; Ended a material agreement; Completed an acquisition or sale¹¹
Jul 7, 20238-K Entered a material agreement¹²
Jun 26, 20238-K Entered a material agreement¹³
Jun 20, 20238-K Other events¹⁴
Dec 12, 20228-K Entered a material agreement; Change in control; Executive or director change¹⁵
Mar 16, 20228-K Earlier financial statements no longer reliable¹⁶

25 filings to the SEC since October 2021: 3 annual reports, 11 quarterly reports, 8 major events, 3 other. The latest 20:

The 25 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

How SYBLEU Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

Name on EDGARSYBLEU Inc¹
CIK0001818674
Employer ID (EIN)85-1412307¹
Filer status<br>emerging growth company¹
Incorporated inWyoming¹
Fiscal year endsJune 30¹
Industry code (SIC)2834 Pharmaceutical Preparations¹
SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance¹
Business address1034 Throggs Neck Expressway, Bronx, NY 10465¹
Phone718-795-7790¹
Shares outstanding10,613,492 as of Dec 31, 2023⁷
Public float$0 as of Jun 30, 2023²
On EDGAR sinceAug 17, 2020¹
Filings45 in all: 10-Q (11), 8-K (11), CORRESP (4), 10-K (3), 10-Q/A (3), S-1/A (3), UPLOAD (3), 10-K/A (1)¹
All 14 form types
424B3 (1), EFFECT (1), NT 10-Q (1), S-1 (1), S-8 (1), S-8 POS (1)
Latest filingsAnnual report (10-K) Aug 4, 2023
Quarterly report (10-Q) Jan 23, 2024
Latest 8-K (8-K) May 23, 2024

The numbers on this page point here. Each one links to the record it came from.